Drug Trial Radar · NCT04414163
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
23
Actual
Start
Oct 27, 2020
Primary completion
Jul 23, 2024
Study completion Feb 28, 2027
Sponsor
- Lead sponsor
- ImmuneOncia Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 4, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, Open-label, to investigate the efficacy and safety of IMC-001 in patients with Relapsed or Refractory extranodal NK/T cell lymphoma, nasal type
Conditions
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Extranodal NK/T-cell Lymphoma
Interventions
IMC-001Drug
Single dose level for enrollment subject (IMC-001 20mg/kg every 2 weeks)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of Objective Response Rate(ORR)Time frame: through study completion, an average of 1 year
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Chonnam National University Hwasun Hospital
Gwangju, South Korea
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Ulsan University Hospital
Ulsan, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.